Directory
Marcelino Bermudez Lopez

Marcelino Bermudez Lopez

Degree: PhD

973702482
mbermudez(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/C-3787-2011

Publications

  • GONZALEZ GUTIERREZ, JESSICA; GRACIA LAVEDAN, ESTHER; GÓMEZ FALGUERA, SILVIA; BARRIL FARRE, SILVIA; GODOY GARCIA, PERE; BERMUDEZ LOPEZ, MARCELINO; Betriu, Angels; Fernandez, Elvira; LECUBE TORELLÓ, ALBERT; PAMPLONA GRAS, REINALD; PURROY GARCIA, FRANCISCO; Farras Salles, Cristina; BARBÉ ILLA, FERRAN; TORRES CORTADA, GERARD; DE BATLLE GARCIA, JORDI

    Lung Function Impairment Is Related to Subclinical Atherosclerosis Only in Active Smokers

    Vasa-European Journal of Vascular Medicine -. .

    [doi:10.3390/jvd1010004]

  • Bermúdez-López M; Martí-Antonio M; Castro-Boqué E; Bretones MDM; Farràs C; Torres G; Pamplona R; Lecube A; Mauricio D; Valdivielso JM; Fernández E

    Development and Validation of a Personalized, Sex-Specific Prediction Algorithm of Severe Atheromatosis in Middle-Aged Asymptomatic Individuals: The ILERVAS Study.

    Frontiers in Cardiovascular Medicine 9 895917-895917. .

    [doi:10.3389/fcvm.2022.895917]

  • Sánchez E; Kerkeni M; Hernández M; Gavaldà R; Rius F; Sauret A; Torres G; Bermúdez-López M; Fernández E; Castro-Boqué E; Purroy F; Mauricio D; Farràs-Sallés C; Buti M; Godoy P; Pamplona R; Lecube A

    Weak Association between Skin Autofluorescence Levels and Prediabetes with an ILERVAS Cross-Sectional Study.

    Nutrients 14 -. .

    [doi:10.3390/nu14051102]

  • Sanchez, E; Sapiña-Beltrán E; Gavalda, R; Barbe, F; Torres, G; Sauret, A; Dalmases, M; Lopez-Cano, C; Gutierrez-Carrasquilla, L; Bermudez-Lopez, M; Fernandez, E; Purroy, F; Castro-Boque, E; Farràs-Sallés C; Pamplona, R; Mauricio, D; Hernandez, C; Simo, R; Lecube, A

    Prediabetes Is Associated with Increased Prevalence of Sleep-Disordered Breathing.

    Journal of Clinical Medicine 11 -. .

    [doi:10.3390/jcm11051413]

  • Núñez E; Fuster, V; Gomez-Serrano, M; Valdivielso, JM; Fernandez-Alvira, JM; Martinez-Lopez, D; Rodriguez, JM; Bonzon-Kulichenko, E; Calvo, E; Alfayate, A; Bermudez-Lopez, M; Escola-Gil, JC; Fernandez-Friera, L; Cerro-Pardo, I; Mendiguren, JM; Sanchez-Cabo, F; Sanz, J; Ordovas, JM; Blanco-Colio, LM; Garcia-Ruiz, JM; Ibáñez B; Lara-Pezzi, E; Fernandez-Ortiz, A; Martin-Ventura, JL; Vazquez, J

    Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis.

    EBioMedicine 76 103874-103874. .

    [doi:10.1016/j.ebiom.2022.103874]

  • Purroy F; Sánchez E; Lecube A; Arqué G; Vicente-Pascual M; Mauri-Capdevila G; Torreguitart N; Hernández M; Barbé F; Fernández E; Pamplona R; Farràs C; Mauricio D; Bermúdez-López M

    Prevalence and Predictors of Cerebral Microangiopathy Determined by Pulsatility Index in an Asymptomatic Population From the ILERVAS Project.

    Frontiers in Neurology 12 785640-785640. .

    [doi:10.3389/fneur.2021.785640]

  • Castelblanco E; Hernández M; Ortega E; Amigó N; Real J; Granado-Casas M; Miñambres I; Lopez C; Lecube A; Bermúdez-López M; Alonso N; Julve J; Mauricio D

    Outstanding improvement of the advanced lipoprotein profile in subjects with new-onset type 1 diabetes mellitus after achieving optimal glycemic control.

    DIABETES RESEARCH AND CLINICAL PRACTICE 182 109145-109145. .

    [doi:10.1016/j.diabres.2021.109145]

  • Bermudez-Lopez M; Perpiñan H; Amigo N; Castro E; Alonso N; Mauricio D; Fernandez E; Valdivielso JM

    Advanced lipoprotein parameters could better explain atheromatosis in non-diabetic chronic kidney disease patients.

    CLINICAL KIDNEY JOURNAL 14 2591-2599. .

    [doi:10.1093/ckj/sfab113]

  • Bermúdez-López M; Martínez-Alonso M; Castro-Boqué E; Betriu À; Cambray S; Farràs C; Barbé F; Pamplona R; Lecube A; Mauricio D; Purroy F; Valdivielso JM; Fernández E; ILERVAS project collaborators

    Subclinical atheromatosis localization and burden in a low-to-moderate cardiovascular risk population: the ILERVAS study.

    Revista espanola de cardiologia (English ed.) 74 1042-1053. .

    [doi:10.1016/j.rec.2020.09.015]

  • Castelblanco E; Sarrias MR; Betriu À; Soldevila B; Barranco-Altirriba M; Franch-Nadal J; Valdivielso JM; Bermudez-Lopez M; Groop PH; Fernández E; Alonso N; Mauricio D

    Circulating CD5L is associated with cardiovascular events and all-cause mortality in individuals with chronic kidney disease.

    Aging-US 13 22690-22709. .

    [doi:10.18632/aging.203615]

  • Bozic, Milica; Diaz-Tocados, Juan M.; Bermudez-Lopez, Marcelino; Forne, Carles; Martinez, Cristina; Fernandez, Elvira; Valdivielso, Jose M.

    Independent effects of secondary hyperparathyroidism and hyperphosphatemia on chronic kidney disease progression and cardiovascular events: an analysis from the NEFRONA cohort.

    NEPHROLOGY DIALYSIS TRANSPLANTATION 37 1-10. .

    [doi:10.1093/ndt/gfab184]

  • Sánchez M; Sánchez E; Bermúdez-López M; Torres G; Farràs-Sallés C; Pamplona R; Castro-Boqué E; Valdivielso JM; Purroy F; Martínez-Alonso M; Godoy P; Mauricio D; Fernández E; Hernández M; Rius F; Lecube A

    Clinical Usefulness of Anthropometric Indices to Predict the Presence of Prediabetes. Data from the ILERVAS Cohort.

    Nutrients 13 1-15. .

    [doi:10.3390/nu13031002]

Projects

  • ANGEL: A machine learning algorithm to predict atherosclerotic cardiovascular disease.
  • Development of dynamic models for the personalized prevention and treatment of age-related diseases
  • Impacto del Manejo de los Trastornos Respiratorios Durante el Sueño en el control de la hipertensión sistémica: Proyecto METASLEEP
  • Influence of SARS-COV-2 infection in atherosclerosis development. “El BUS DE LA SALUT” study
  • Papel de PTEN en la reabsorcion tubular renal de proteinas. Implicaciones en nefropatias proteinuricas
  • Projecte d'Investigació ILERVAS - 2022
  • Ayudas Juan de la Cierva - Incorporación 2018
  • Projecte d'investigació ILERVAS -2020 Diputació
  • Caracterización de un perfil lipidomico y lipídico de riesgo aterogénico y de morbimortalidad cardiovascular en la enfermedad renal crónica (estadios 3 a 5) (estudio prospectivo NEFRONA)
  • AJUT PER A LA CONTRACTACIÓ D'UN NOU INVESTIGADOR